The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded Medical Research Council (MRC) Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease.
We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
Medical Research Council Metabolic Diseases Unit
The IMS-MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Wellcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the IMS-MRL.
We continue to follow Government and University of Cambridge guidelines for staying COVID-safe.
Equality, diversity, inclusion and wellbeing
We aspire to be a place where everyone feels welcome, included, safe and heard.
Skinny genes – the genetics behind body weight
Live from the lab – do you want to see what it’s like to work in our Institute? Four short films for young people
Congratulations to Professors Sue Ozanne and David Savage on being elected as Fellows of the Academy of Medical Sciences. They join 60 other new…
Congratulations to Steve O’Rahilly and Sadaf Farooqi on delivering the 2022 Royal Society’s Croonian Lecture on 14 April 2022 to a packed auditorium at…
New research shows that an enzyme produced by macrophages (immune system cells) in fat tissue plays an essential role in the loss of metabolic…
Aliki Perdikari and colleagues from the Farooqi team have developed a technique to visualize sympathetic innervation of human white adipose tissue for the first…